Jaguar Health has unveiled its financial results for the third quarter of 2024, indicating notable strides in growth and development. The announcement revealed a significant increase in net revenue and highlighted the company's continued advancement in its core programs, underscoring its resilience
Evaxion Biotech A/S, a clinical-stage biotech firm listed on Nasdaq under the ticker EVAX, is currently navigating a challenging landscape as it appeals a delisting determination from Nasdaq. This stems from non-compliance with the minimum stockholder equity requirement of $2.5 million stipulated
Shares of Amgen edged up in premarket trading after the firm's announcement that its experimental obesity drug, MariTide, does not negatively impact bone mineral density. This comes following a more than 7% plunge in stock due to a report by Cantor Fitzgerald analysts, which had cited data implying
The growing conversational AI market is transforming enterprise customer service and providing new investment opportunities. Conversational AI technology, which includes natural language processing (NLP), machine learning, and automatic speech recognition, is at the forefront of this shift,
GE HealthCare's recent announcement of the FDA 510(k) clearance for its SIGNA MAGNUS, a 3.0T head-only MRI scanner, marks a revolutionary advancement in MRI technology specifically tailored for neuroimaging applications. This landmark development in medical imaging is poised to significantly
Avidity Biosciences, Inc., a pioneering biopharmaceutical company, has made a significant leap in the realm of RNA therapeutics by introducing its latest initiatives in precision cardiology. This expansion is marked by the company's unveiling of two new wholly-owned development candidates—AOC 1086
